Republicans unveil a new healthcare plan

Members of the Congressional Republican Study Committee released a new healthcare plan from the party, The Hill reported.

The emergence of the plan comes as the upcoming 2020 presidential election heats up and Democratic candidates take on Medicare for all proposals. Attacking the Affordable Care Act has been a platform staple of the Republican party over the last several years and elections.

Republicans are also behind the ACA’s greatest legal challenge yet after launching a lawsuit to overturn it. Late last year, a federal judge found the law unconstitutional, but the case is currently in the appeals process. According to members of the committee, the plan is meant to act as an alternative to Medicare for all plans promoted by Democrats.

In part, the plan establishes high-risk pools instead of providing subsidies for those to purchase individual insurance on the federal marketplace. It would also weaken the essential health benefits requirements of the ACA––a key provision of the law––by allowing states to decide which benefits to cover.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup